Clinical Trials on Treatment Of Stenotic Lesions In Native Coronary Arteries. in Belgium

Total 4 results

Biotronik AG

Completed

First in Man Trial - BIOSOLVE-I (BIOSOLVE-I)

de Novo Lesions in Native Coronary Arteries

Netherlands, Switzerland, Germany, Belgium
Abbott Medical Devices

Completed

ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients.

Coronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery Restenosis

Belgium
Abbott Medical Devices

Recruiting

Abbott Vascular Medical Device Registry (AV-MDR)

Acute Myocardial Infarction | Restenoses, Coronary | Coronary Artery Lesions | Venous Embolism | Arterial Embolism

United States, China, Hungary, Spain, Germany, Austria, Australia, Belgium, France, Italy, Netherlands, Switzerland, Taiwan, United Arab Emirates
Universitair Ziekenhuis Brussel

Recruiting

Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis (MITRAS)

Cancer | Carotid Stenosis | Non Hodgkin Lymphoma | Sarcoidosis | Cardiac Sarcoidosis | Hodgkin Lymphoma, Adult | Atherosclerosis of Artery | HLH | Solid Malignancy Located in the Head and Neck

Belgium

3

Subscribe